{"id":"https://openalex.org/W2002183411","doi":"https://doi.org/10.1158/1538-7445.am2011-1303","title":"Abstract 1303: Characterization of the metabolite profile for batracylin and N-acetylbatracylin in rat and human models of invitro and in vivo metabolism: Elucidation of pathways that might contribute to batracylin toxicity","display_name":"Abstract 1303: Characterization of the metabolite profile for batracylin and N-acetylbatracylin in rat and human models of invitro and in vivo metabolism: Elucidation of pathways that might contribute to batracylin toxicity","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2002183411","doi":"https://doi.org/10.1158/1538-7445.am2011-1303","mag":"2002183411"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-1303","doi":"https://doi.org/10.1158/1538-7445.am2011-1303","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-1303","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066722006","display_name":"Matthew M. Ames","orcid":"https://orcid.org/0000-0003-3652-209X","observed_orcids":["https://orcid.org/0000-0003-3652-209X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew M. Ames","raw_affiliation_strings":["1Mayo Clinic, Rochester, MN","#N#1Mayo Clinic, Rochester, MN#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"#N#1Mayo Clinic, Rochester, MN#N#","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027416118","display_name":"Joel M. Reid","orcid":"https://orcid.org/0000-0003-2872-3123","observed_orcids":["https://orcid.org/0000-0003-2872-3123"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel M. Reid","raw_affiliation_strings":["1Mayo Clinic, Rochester, MN","#N#1Mayo Clinic, Rochester, MN#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"#N#1Mayo Clinic, Rochester, MN#N#","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012302982","display_name":"Sarah A. Buhrow","orcid":"https://orcid.org/0009-0003-5723-5409","observed_orcids":["https://orcid.org/0009-0003-5723-5409"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah A. Buhrow","raw_affiliation_strings":["1Mayo Clinic, Rochester, MN","#N#1Mayo Clinic, Rochester, MN#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"#N#1Mayo Clinic, Rochester, MN#N#","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110666944","display_name":"Mary J. Kuffel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary J. Kuffel","raw_affiliation_strings":["1Mayo Clinic, Rochester, MN","#N#1Mayo Clinic, Rochester, MN#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"#N#1Mayo Clinic, Rochester, MN#N#","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076139916","display_name":"Chad A. Walden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chad A. Walden","raw_affiliation_strings":["1Mayo Clinic, Rochester, MN","#N#1Mayo Clinic, Rochester, MN#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"#N#1Mayo Clinic, Rochester, MN#N#","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034690406","display_name":"Joseph M. Covey","orcid":"https://orcid.org/0000-0002-5696-8999","observed_orcids":["https://orcid.org/0000-0002-5696-8999"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Covey","raw_affiliation_strings":["2National Cancer Institute, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2National Cancer Institute, Rockville, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079240159","display_name":"Holger Peter Behrsing","orcid":"https://orcid.org/0000-0001-7284-9837","observed_orcids":["https://orcid.org/0000-0001-7284-9837"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Holger P. Behrsing","raw_affiliation_strings":["3National Cancer Institute, Frederick, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3National Cancer Institute, Frederick, MD","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064398802","display_name":"Myrtle Davis Millin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Myrtle Davis Millin","raw_affiliation_strings":["2National Cancer Institute, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2National Cancer Institute, Rockville, MD","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"1303","last_page":"1303"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-acetyltransferase-2","display_name":"N-acetyltransferase 2","score":0.8550000190734863},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.6909999847412109},{"id":"https://openalex.org/keywords/metabolic-profiling","display_name":"metabolite profiling","score":0.722000002861023},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.7929999828338623},{"id":"https://openalex.org/keywords/hematuria","display_name":"hematuria","score":0.5519999861717224},{"id":"https://openalex.org/keywords/hemorrhagic-cystitis","display_name":"hemorrhagic cystitis","score":0.8140000104904175},{"id":"https://openalex.org/keywords/hydroxylation","display_name":"hydroxylation","score":0.6100000143051147},{"id":"https://openalex.org/keywords/carboxylesterase","display_name":"carboxylesterase","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cyp1a2","display_name":"CYP1A2","score":0.5569999814033508},{"id":"https://openalex.org/keywords/cyp2c8","display_name":"CYP2C8","score":0.5550000071525574},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.6679999828338623},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.7450000047683716},{"id":"https://openalex.org/keywords/cyp2b6","display_name":"CYP2B6","score":0.5590000152587891},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.5770000219345093},{"id":"https://openalex.org/keywords/cyp2c20","display_name":"CYP2C20","score":0.5019999742507935},{"id":"https://openalex.org/keywords/cyp2c39","display_name":"CYP2C39","score":0.4779999852180481},{"id":"https://openalex.org/keywords/cyp2c38","display_name":"CYP2C38","score":0.48500001430511475},{"id":"https://openalex.org/keywords/cyp2c37","display_name":"CYP2C37","score":0.49399998784065247},{"id":"https://openalex.org/keywords/cyp2c33","display_name":"CYP2C33","score":0.7480000257492065},{"id":"https://openalex.org/keywords/cyp2c31","display_name":"CYP2C31","score":0.8050000071525574},{"id":"https://openalex.org/keywords/cyp2c30","display_name":"CYP2C30","score":0.7910000085830688},{"id":"https://openalex.org/keywords/cyp2c29","display_name":"CYP2C29","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cyp2c28","display_name":"CYP2C28","score":0.9070000052452087},{"id":"https://openalex.org/keywords/cyp2c27","display_name":"CYP2C27","score":0.859000027179718},{"id":"https://openalex.org/keywords/cyp2","display_name":"CYP2","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7595562934875488},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6187291145324707},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.6026666760444641},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5894361734390259},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5518088936805725},{"id":"https://openalex.org/C2777071529","wikidata":"https://www.wikidata.org/wiki/Q12796879","display_name":"Mitochondrial toxicity","level":3,"score":0.5500933527946472},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5341433882713318},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5233684778213501},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.43752846121788025},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4137049913406372},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.37705448269844055},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34794485569000244},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.11589950323104858},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-1303","doi":"https://doi.org/10.1158/1538-7445.am2011-1303","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-1303","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1977921226","https://openalex.org/W2465059770","https://openalex.org/W2160812530","https://openalex.org/W2007709024","https://openalex.org/W2050448027","https://openalex.org/W356927717","https://openalex.org/W306911265","https://openalex.org/W2048120675","https://openalex.org/W2073509461","https://openalex.org/W2344375302"],"abstract_inverted_index":{"Abstract":[0],"Batracylin":[1],"(NSC":[2],"320846,":[3],"BAT)":[4],"is":[5,55,66,105,127],"a":[6,56,73,108,218,402],"heterocyclic":[7],"arylamine":[8],"and":[9,25,91,107,143,148,154,156,163,168,172,182,191,196,205,226,228,255,281,301,313,323,329,335,342,344,353,358,375,382,394,400],"topoisomerase":[10],"II":[11],"inhibitor":[12],"that":[13,53,232,320],"was":[14,50,115,245,272],"shown":[15,52],"to":[16,34,41,43,69,96,103,122,129,177,216,229,235,274,409],"be":[17],"active":[18],"in":[19,32,86,117,138,145,158,165,187,224,253,259,266,288,333,349,350,360,373,379,392,395],"several":[20,118],"murine":[21],"tumor":[22],"models.":[23],"Pharmacology":[24],"toxicology":[26],"studies":[27,355,384],"demonstrated":[28],"marked":[29],"species":[30],"differences":[31],"sensitivity":[33],"the":[35,98,137,157,316,391,427,432],"toxic":[36,411],"effects":[37],"of":[38,64,75,84,100,112,141,161,212,243,249,268,290,327,369,398,407,426,431],"BAT":[39,54,85,142,162,174,223,236,244,300,322,328,341,357,399,408],"attributed":[40,273],"metabolism":[42,140,160,352,381,397],"N-acetylbatracylin":[44],"(NacBAT)":[45],"by":[46,198,247,276,414],"N-acetyltransferase":[47],"(NAT).":[48],"It":[49],"subsequently":[51],"preferential":[57],"substrate":[58],"for":[59,222,404,435],"human":[60,146,336],"NAT2;":[61],"thus":[62],"production":[63],"NacBAT":[65,104,144,164,184,190,269,284,291,330,359],"likely":[67],"subject":[68],"population":[70],"variability":[71],"as":[72,208,315],"function":[74],"known":[76],"NAT2":[77,94],"polymorphisms.":[78],"A":[79],"phase":[80],"I":[81],"clinical":[82],"trial":[83],"patients":[87],"with":[88,200,270,292,298,304,356,366,385],"advanced":[89],"cancer":[90],"slow":[92],"acetylator":[93],"genotypes":[95],"reduce":[97],"risk":[99],"toxicity":[101,111,126],"due":[102,128],"ongoing":[106],"potentially":[109],"dose-limiting":[110],"cystitis/hemorrhagic":[113],"cystitis":[114],"observed":[116],"patients.":[119],"In":[120,238,387],"order":[121],"determine":[123],"if":[124],"this":[125],"BAT,":[130,189,370],"NacBAT,":[131,339,343],"and/or":[132],"other":[133],"metabolites,":[134],"we":[135,389],"investigated":[136],"vitro":[139,393],"(h)":[147],"rat":[149,334],"(r)":[150],"liver":[151],"microsomes":[152],"(LM)":[153],"hepatocytes,":[155],"vivo":[159,351,380,396],"rats.":[166,361,386],"14C-BAT":[167],"differentially":[169],"deuterated":[170,299],"(d3-":[171],"d4-)":[173],"were":[175,185,194,215,286,296,331,347,371],"provided":[176],"facilitate":[178],"metabolic":[179,220,367,405],"profiling.":[180],"d3-":[181],"d4-":[183],"generated":[186],"situ.":[188],"their":[192],"metabolites":[193,258,285],"detected":[195,348],"quantified":[197],"HPLC":[199],"diode":[201],"array,":[202],"fluorescence,":[203],"radiochemical":[204],"mass":[206],"spectrometry":[207],"appropriate.":[209],"The":[210,261],"goals":[211],"these":[213],"investigations":[214],"obtain":[217],"detailed":[219],"profile":[221],"rats":[225],"humans":[227],"elucidate":[230],"pathways":[231],"might":[233],"contribute":[234],"toxicity.":[237],"NADPH-fortified":[239],"microsomal":[240,277],"preparations,":[241],"loss":[242],"accompanied":[246],"formation":[248],"one":[250],"hydroxylated":[251,257,263,340],"metabolite":[252,264],"hLM":[254,271],"three":[256],"rLM.":[260,293],"single":[262],"found":[265,287],"incubations":[267,289],"deacetylation":[275],"carboxlesterase.":[278],"Six":[279],"mono-":[280],"di-":[282],"hydroxy":[283],"Hydroxylation":[294],"sites":[295],"identified":[297,309,332,372,401],"NacBAT.":[302,324],"Incubation":[303],"recombinant":[305],"cytochomes":[306],"P450":[307],"(CYPs)":[308],"rCYP1A1,":[310],"rCYP1A2,":[311],"hCYP1A1":[312],"hCYP1B1":[314],"major":[317],"CYP":[318],"isoforms":[319],"metabolize":[321],"Glucuronide":[325],"conjugates":[326,346],"hepatocyte":[337],"incubations.":[338],"glucuronide":[345],"pharmacokinetic":[354,383],"Finally,":[362],"thiol-containing":[363],"adducts,":[364],"consistent":[365],"activation":[368,406],"kidney":[374],"urine":[376],"samples":[377],"from":[378],"conclusion,":[388],"characterized":[390],"pathway":[403],"potential":[410],"metabolites.":[412],"Supported":[413],"NCI":[415],"Contract":[416],"N01-CM-52206.":[417],"Citation":[418],"Format:":[419],"{Authors}.":[420],"{Abstract":[421],"title}":[422],"[abstract].":[423],"In:":[424],"Proceedings":[425],"102nd":[428],"Annual":[429],"Meeting":[430],"American":[433],"Association":[434],"Cancer":[436,446],"Research;":[437],"2011":[438],"Apr":[439],"2-6;":[440],"Orlando,":[441],"FL.":[442],"Philadelphia":[443],"(PA):":[444],"AACR;":[445],"Res":[447],"2011;71(8":[448],"Suppl):Abstract":[449],"nr":[450],"1303.":[451],"doi:10.1158/1538-7445.AM2011-1303":[452]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}